DFX Intelligence
Data Factory
Reading the graph
Reading the graph
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Expanding the Possibilities of in vivo Gene Therapy The promise of in vivo gene therapy has been constrained by the limits of delivery, holding back the full potential of transformative science.S•••.BIO is redefining what’s possible, enabling therapies to be designed around disease biology, instead of delivery tradeoffs. Learn more Gene Therapy Shaped by Therapeutic NeedS•••.BIO […]
Data as of (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Investor | Class | Fund | Partner | Role | Attribution |
|---|---|---|---|---|---|
| D•••• A•••••••• I••• | Institutional VC | n/a | n/a | unknown | Unknown |
| K•• V••••••• | Institutional VC | n/a | n/a | unknown | Unknown |